Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Genus plc ( (GB:GNS) ) just unveiled an update.
Genus plc announced the vesting of 44,933 nil-cost options granted over ordinary shares, with CEO Jorgen Kokke selling 19,967 shares to cover tax liabilities and retaining 24,966 shares. This transaction highlights the company’s ongoing management of executive compensation and shareholding strategies, reflecting its commitment to aligning leadership interests with shareholder value.
More about Genus plc
Genus plc operates in the biotechnology industry, focusing on animal genetics and breeding. The company provides advanced genetic products and services to the agricultural sector, aiming to enhance animal breeding and production efficiency.
YTD Price Performance: 12.90%
Average Trading Volume: 131,545
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £1.15B
Learn more about GNS stock on TipRanks’ Stock Analysis page.